Digital gangrene: can be the first manifestation of essential thrombocythemia? a case report

Author:

Mirhosseini Amirhossein1,Bozorgmehr Ramin2,Bastan Fatemeh34,Rashidian Maryam34

Affiliation:

1. Department of Hematology and Oncology

2. Department of General Surgery, Imam Ali Hospital

3. Student Research Committee, School of Medicine

4. Alborz Office of USERN, Universal Scientific Education and Research Network (USERN), Alborz University of Medical Sciences, Karaj, Iran

Abstract

Introduction and importance: Essential thrombocythemia (ET) is a rare chronic myeloproliferative hematologic disorder, leading to an elevated platelet count. Two-thirds of patients are asymptomatic during their lifetime, while others may experience symptoms like redness, congestion, and erythromelalgia after long symptom-free intervals. Case presentation: The authors present a rare instance of a 55-year-old female who, despite receiving aspirin and losartan treatment, eventually developed digital gangrene. In further work-ups, she had an elevated platelet count and a positive JAK 2 mutation. Her platelet count was reduced throughout treatment with aspirin, hydroxyurea, and heparin, which was followed by the necrotic tip of her index finger being surgically debrided. Clinical discussion: Significant symptoms, such as severe acrocyanosis and even peripheral gangrene, can be treated with a single dose of aspirin. Daily aspirin consumption withstanding, this case developed the severe form of ET. In addition, while thrombocytosis predisposes patients to thrombotic complications in theory, there is little evidence to support a correlation between absolute platelet count and thrombosis. Conclusion: The initial symptom of ET could be such severe and uncommon that may develop arterial acral thrombosis despite previous daily low-dose aspirin consumption.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference10 articles.

1. Essential thrombocythemia: a review of diagnostic and pathologic features;Sanchez;Arch Pathol Lab Med,2006

2. The essential thrombocythemia in 2020: what we know and where we still have to dig deep;Accurso;Clin Med Insights Blood Disord,2020

3. The scare 2023 guideline: updating consensus surgical case report (scare) guidelines;Sohrabi;Int J Surg,2023

4. Arterial thrombosis in essential thrombocythemia;Hussain;Am Heart J,1978

5. Myeloproliferative disorders;Meier;Hematol Oncol Clin North Am,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3